Porcine Astrovirus

Overview and Taxonomy of Porcine Astrovirus

Porcine astrovirus (PAstV) represents a globally pervasive, genetically heterogeneous group of enteric viruses within the family Astroviridae, genus Mamastrovirus, that has emerged as a significant pathogen of swine, contributing to both enteric and extra-intestinal disease syndromes [1, 3, 5]. The recognition of PAstV as a pathogen of economic and veterinary public health importance has grown exponentially over the past two decades, driven by its consistent detection in diarrheic and neurologically affected piglets, its frequent involvement in polymicrobial infections, and the accumulating evidence of its capacity for cross-species transmission [1, 8, 13]. The World Organisation for Animal Health (WOAH) has noted the increasing complexity of enteric disease complexes in swine, among which PAstV is a prominent, though often overlooked, component, contributing to substantial economic losses in the global swine industry through mortality, growth retardation, and the costs associated with diagnostic and control interventions [1, 9].

Taxonomically, the genus Mamastrovirus encompasses astroviruses infecting mammalian hosts, with PAstVs currently delineated into five distinct genotypes, designated PAstV-1 through PAstV-5 [3, 4, 16, 27]. This genotypic classification is primarily based on the genetic divergence of the complete capsid protein (Open Reading Frame 2; ORF2) and, to a lesser extent, the RNA-dependent RNA polymerase (RdRp) region within ORF1b [3, 4, 16, 22]. The demarcation criteria for these genotypes typically involve nucleotide sequence identities of less than 68–70% for ORF2, a threshold that aligns with the classification standards for other mammalian astroviruses. While PAstV-1 was historically the first to be recognized and characterized, subsequent metagenomic and molecular epidemiological surveys have revealed the widespread and often co-circulating nature of all five genotypes across diverse geographic regions, including Asia, Europe, North America, South America, and Africa [1, 24, 28, 29]. The high genetic variability, particularly within the capsid-encoding region, is a hallmark of astrovirus biology and poses significant challenges for the development of broadly reactive diagnostic assays and cross-protective vaccines [16, 18, 23].

Genomic Organization and Virion Structure

The PAstV genome is a single-stranded, positive-sense RNA molecule, typically ranging from 6.2 to 6.5 kilobases (kb) in length, excluding the poly-A tail, and is organized into three principal open reading frames (ORFs): ORF1a, ORF1b, and ORF2, flanked by 5′ and 3′ untranslated regions (UTRs) [2, 9, 20]. A conserved ribosomal frameshifting signal, often involving a heptanucleotide slippery sequence and a downstream pseudoknot structure, lies at the junction of ORF1a and ORF1b, facilitating the translation of the ORF1ab polyprotein [21]. This subgenomic strategy is a defining feature of the Astroviridae. ORF1a and ORF1ab encode nonstructural proteins, including the serine protease (nsP1a/3), the genome-linked viral protein (VPg), and the RNA-dependent RNA polymerase (RdRp), respectively, which are essential for viral replication and modulation of the host cellular environment [2, 6, 14]. The nsP1a polyprotein undergoes proteolytic cleavage to yield at least four distinct products, including nsP1a/4, which has been demonstrated to antagonize the host type I interferon (IFN) response through interaction with the signaling molecules MAVS and IRF3, thereby facilitating viral replication [6]. Furthermore, the nsP1a/3 protease possesses a 3C-like serine protease activity that not only mediates polyprotein processing but also induces mitochondrial apoptosis and cleaves MAVS, further suppressing the IFN response [14]. These intricate immune evasion strategies are critical for the establishment of infection and underscore the complex virus-host interactions at play.

In contrast, ORF2 encodes the single structural capsid protein precursor, VP90 (~90 kDa), which is a key determinant of antigenicity, host cell tropism, and viral entry [5, 7, 10]. Recent structural studies, including the determination of the PAstV-4 capsid spike protein crystal structure at 1.85 Å resolution, have revealed a conserved core domain and a surface-exposed spike domain that are critical for antibody recognition and host cell interactions [10]. The maturation of the infectious virion involves a unique and strictly regulated extracellular proteolytic cascade. Unlike human astrovirus, which undergoes an intracellular cleavage of VP90 to VP70 via cellular caspases, the capsid precursor of PAstV is released from infected cells in its unprocessed, non-infectious VP90 form [5]. Extracellular trypsin, likely derived from the host gastrointestinal tract, is then essential for processing VP90 into the mature capsid proteins VP34, VP30, and VP27 (and a smaller VP25 fragment), which constitute the structural subunits of the fully infectious viral particle [5]. This trypsin-dependent maturation step is an absolute requirement for PAstV infectivity, linking the viral life cycle intimately to the host intestinal environment. Additionally, a novel overlapping gene, ORF2b, embedded within ORF2, has been identified in PAstV-1, encoding a small non-structural protein that is important for optimal viral infectivity, though not essential for replication [20].

Genetic Diversity, Recombination, and Zoonotic Potential

The genetic diversity of PAstVs is extraordinary, driven by the accumulation of point mutations, insertions/deletions (indels), and, most significantly, recombination events [2, 4, 12, 21, 23, 24]. Recombination, particularly within the ORF2 and ORF1b regions, has been identified as a major evolutionary force generating novel viral lineages and contributing to the complex phylogenetic landscape observed in global PAstV populations [21, 23, 24]. Inter-genotype and intra-genotype recombination events have been frequently documented, including potential recombination between porcine and deer astroviruses, suggesting a history of interspecies transmission and genetic exchange at the wildlife-domestic animal interface [23]. A comprehensive phylodynamic analysis of PAstV-3 strains estimated that its most recent common ancestor (tMRCA) emerged around the year 1660, and the effective population size has been continuously expanding, indicating an ongoing adaptive evolution and dissemination [4].

The ecological and public health implications of PAstV diversity are profound. There is accumulating evidence for the potential for cross-species transmission. Porcine astrovirus type 5 (PAstV-5) has been detected in Bactrian camels (Camelus bactrianus) in China, marking the first report of this porcine virus in a non-porcine host and raising concerns about viral spillover into other livestock species [13]. Furthermore, the detection of PAstV sequences in the brains of pigs with polioencephalomyelitis, particularly PAstV-3, has established the neurotropic potential of this genotype, with experimental oral and intravenous inoculations successfully reproducing neurological disease in cesarean-derived, colostrum-deprived piglets [8, 11, 15, 17, 25]. This ability to infect the central nervous system (CNS), likely via axonal transport from the enteric nervous system, mirrors the neuroinvasive pathology observed with human astrovirus infections, particularly in immunocompromised individuals [11, 15, 19]. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have increasingly recognized the importance of monitoring astroviruses, including porcine strains, as part of a "One Health" approach to emerging infectious diseases, given their widespread distribution, high genetic plasticity, and demonstrated capability to cross species barriers [26]. The high prevalence of asymptomatic infections, which has been estimated to be as high as 36.71% in some meta-analyses, further complicates control efforts and indicates that a large, undetected reservoir of the virus persists in pig populations, perpetuating transmission cycles [1].

Molecular Pathogenesis and Oxidative Stress in PAstV Replication

The elucidation of the molecular pathogenesis of porcine astrovirus (PAstV) has been historically constrained by the difficulties inherent in in vitro virus isolation and the lack of robust reverse genetics systems [2, 34]. However, recent breakthroughs in the isolation of multiple genotypes, particularly PAstV1, PAstV4, and PAstV5, have catalyzed a paradigm shift in our understanding of the virus–host interface [2, 9, 12, 33]. A central and recurring theme emerging from these studies is the intimate and multifaceted connection between PAstV replication and the induction of cellular oxidative stress, specifically through mitochondrial dysfunction, the dysregulation of reactive oxygen species (ROS), and the subversion of host antioxidant defense systems [2, 12, 14, 30]. These processes are not merely epiphenomena of cytopathic effect but are mechanistically linked to viral replication efficiency, apoptotic signaling, and the suppression of the host type I interferon (IFN) response [2, 14, 31].

Mitochondrial Dysfunction as a Central Hub of PAstV-Induced Cellular Stress

The mitochondrion has emerged as a primary intracellular target during PAstV infection, serving as both a source of pro-viral signaling molecules and a battleground for innate immune antagonism [2, 12, 14, 30]. Quantitative proteomics of PAstV4-infected Caco-2 cells has explicitly demonstrated that mitochondria are a primary organelle targeted by viral infection, with global protein changes converging on pathways of mitophagy and apoptosis [12]. This finding has been corroborated at the functional level using the newly isolated PAstV5-GX2 strain in PK-15 cells, where infection leads to profound mitochondrial ultrastructural damage. Transmission electron microscopy has revealed characteristic swelling of the mitochondrial matrix, disruption and loss of cristae, and the appearance of cytoplasmic vacuolization [2]. Concomitant with these structural changes, PAstV infection induces a significant reduction in mitochondrial membrane potential (ΔΨm), a critical parameter for ATP synthesis and cellular homeostasis [2]. The loss of ΔΨm is a classical hallmark of mitochondrial permeability transition pore opening and is a potent trigger for the intrinsic pathway of apoptosis.

The functional consequence of this mitochondrial damage is the hyperproduction of mitochondrial-derived ROS (mtROS). Using the MitoSOX probe, which specifically targets superoxide anions within the mitochondrial matrix, a marked increase in mtROS was detected in PAstV5-GX2-infected PK-15 cells [2]. This event is coupled with a dramatic downregulation of the cellular antioxidant defense system. Specifically, the protein expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream target heme oxygenase-1 (HO-1) are significantly diminished [2]. Nrf2 is a master transcriptional regulator of the antioxidant response; its suppression by PAstV indicates a direct viral strategy to disable the cell’s capacity to neutralize the oxidative burst, thereby creating a pro-oxidative intracellular environment. The functional importance of this ROS induction for the virus life cycle has been demonstrated through pharmacological manipulation. Exogenous application of hydrogen peroxide (H₂O₂), a potent ROS inducer, significantly enhanced PAstV replication as measured by both immunofluorescence and RT-qPCR. Conversely, treatment with the ROS scavenger N-acetylcysteine (NAC) markedly suppressed viral replication [2]. This confirms a causal and positive feedback loop: PAstV infection drives ROS production, and this elevated ROS state is, in turn, required for optimal viral replication.

Viral Nonstructural Proteins as Orchestrators of Oxidative and Apoptotic Pathways

The molecular agents responsible for triggering mitochondrial dysfunction have been identified as specific nonstructural proteins (nsps) encoded within the ORF1a polyprotein. Among these, the nsP1a/3 protein has been characterized as a critical virulence factor that localizes to the mitochondria and mediates apoptosis via the intrinsic caspase cascade [14]. Using the PAstV1-GX1 strain, it was shown that infection activates caspase-9 and caspase-3, but not caspase-8, confirming engagement of the mitochondrial apoptotic pathway [14]. The nsP1a/3 protein, which possesses a 3C-like serine protease domain, was found to directly interact with the mitochondrial antiviral signaling protein (MAVS). This interaction is dual-purpose. First, it leads to the cleavage of MAVS, effectively dismantling the RIG-I/MDA5 signaling hub that is essential for type I IFN induction [6, 14]. Second, the protease activity is required for the induction of apoptosis; mutating the catalytic triad residues (His459, Asp487, Ser549) of nsP1a/3 abrogated both MAVS cleavage and the apoptotic response [14]. Inhibition of this protease using a serine protease inhibitor or the pan-caspase inhibitor Z-VAD-FMK significantly reduced viral replication, underscoring that these protease-mediated events are essential for virus propagation [14].

A separate nonstructural product, nsP1a/4, contributes to pathogenesis by directly antagonizing interferon-beta (IFN-β) production. This protein interacts with both MAVS and interferon regulatory factor 3 (IRF3), thereby impeding the RIG-I/MDA5 signaling cascade at two critical nodes [6]. This dual blockade ensures that the innate immune response is suppressed even as the virus drives the cell toward apoptosis and oxidative stress. The interplay between these processes is intricate: while the induction of apoptosis can limit virus production in the early stages by destroying the cellular factory, the proteolytic cleavage of MAVIS by nsP1a/3 and the suppression of IRF3 signaling by nsP1a/4 create a temporal window where the virus can replicate efficiently before the host cell is fully dismantled [14, 31].

Another host factor intricately linked to mitochondrial stress is the NOD-like receptor X1 (NLRX1). Proteomics studies identified NLRX1 as a significantly upregulated protein in PAstV4-infected cells [12]. NLRX1 is a unique NLR protein that localizes to the mitochondria and acts as a negative regulator of the RIG-I/MDA5 pathway. Subsequent functional studies confirmed that PAstV4 infection upregulates NLRX1 and induces mitophagy [30]. Silencing of NLRX1 or treatment with the mitophagy inhibitor 3-methyladenine (3-MA) effectively inhibited PAstV4 replication, suggesting that the virus hijacks the mitophagy machinery, likely to clear damaged mitochondria that would otherwise trigger pro-inflammatory signaling [30]. Furthermore, NLRX1 was shown to mediate the disruption of intestinal mucosal integrity via activation of the extracellular regulated protein kinases/myosin light-chain kinase (ERK/MLCK) pathway, leading to the downregulation of tight junction proteins occludin and ZO-1 [30]. This provides a direct molecular link between mitochondrial oxidative stress, innate immune evasion, and the pathogenesis of diarrhea, a hallmark of PAstV infection.

Integration of Oxidative Stress with Innate Immune Evasion and Capsid Maturation

The convergence of oxidative stress and immune evasion is further highlighted by studies on viral co-infections. The first successful isolation of a pure PAstV5 strain (PAstV5-AH29-2014) was achieved not from a mono-infection but from a tissue sample co-infected with classical swine fever virus (CSFV) [34]. It was demonstrated that CSFV coinfection significantly enhanced PAstV5 replication, and this enhancement was mechanistically linked to the suppression of IFN-β production mediated by CSFV [34]. This observation implies that the suboptimal replication of PAstV in vitro is partially due to the host’s intact IFN system, and that the oxidative stress induced by PAstV may further impair the ability of surrounding cells to mount an effective interferon response, creating a permissive microenvironment.

The replication cycle itself is also sensitive to the redox state of the host cell. While the downstream effects of ROS enhance replication, the virus must first successfully enter and uncoat. A recently identified entry factor, Annexin A1 (ANXA1), has been shown to facilitate PAstV entry by directly binding to the acidic C-terminal domain of the capsid protein [32]. While ANXA1 is not directly a ROS sensor, the biophysical properties of this interaction and the membrane dynamics of entry are sensitive to the overall cellular state. Furthermore, once the virus has replicated its genome and translated its capsid precursor (VP90), the final maturation step critical for infectivity is extracellular proteolytic processing by trypsin, which cleaves VP90 into VP25, VP27, VP30, and VP34 [5]. This step is required for the production of mature, infectious virions. It is plausible that the oxidative environment within infected cells could influence the efficiency of this proteolytic cascade or the stability of the mature capsid, although this remains a speculative but fertile area for future investigation.

In summary, PAstV replication is not a passive process but an active manipulation of the host cell’s redox and metabolic machinery. The virus employs a coordinated strategy involving mitochondrial damage, ROS production, and the suppression of antioxidant defenses to create a favorable environment for its own replication. This pro-oxidative state is induced and sustained by the protease activities of nonstructural proteins like nsP1a/3, which simultaneously dismantle the innate immune response through MAVS cleavage and IRF3 antagonism. The resulting oxidative milieu, coupled with the induction of mitophagy via NLRX1, provides the necessary signals for efficient viral genome replication and progeny production, while also contributing to the disruption of intestinal epithelial barriers. These findings position mitochondrial dysfunction and oxidative stress not as mere bystander effects but as central, active drivers of PAstV pathogenesis and replication fitness.

Global Epidemiology and Meta-Analysis of PAstV Prevalence

Porcine astrovirus (PAstV) has emerged as a ubiquitous enteric pathogen of swine, with a global distribution that spans virtually all regions where pig farming is practiced. Understanding the true burden of PAstV infection, its prevalence, geographical variation, temporal trends, and host-specific patterns, is fundamental to assessing its economic impact and designing effective surveillance and control strategies. The most comprehensive synthesis of global PAstV prevalence data to date is the systematic review and meta-analysis conducted by Ge et al. (2025), which pooled data from 45 studies across 10 countries on three continents, encompassing over 376 articles screened from inception through December 2023 [1]. This landmark analysis provides a robust framework for interpreting the complex epidemiological landscape of PAstV infection.

Global and Continental Prevalence Estimates

The global pooled prevalence of PAstV infection, calculated using a random-effects model to account for substantial heterogeneity among studies, stands at 28.19% (95% CI: 21.94%–34.89%) [1]. This figure, however, masks dramatic continental disparities that reflect differences in husbandry practices, biosecurity measures, diagnostic capacity, and circulating viral genotypes. North America exhibits the highest pooled prevalence at 63.24% , a figure driven in large part by extensive surveillance in the United States, where intensive production systems and comprehensive diagnostic programs have revealed near-ubiquitous viral circulation [1, 17, 37, 39]. Europe’s pooled prevalence of 36.19% (95% CI: 34.09%–38.33%) [1] is corroborated by individual country-level studies: for example, a Greek survey of 28 farms found PAstV in 95.4% of pooled fecal samples from asymptomatic pigs, with PAstV3 as the predominant haplotype (91.2%) [46]; Slovakian studies reported viral RNA in 94.4% of healthy and 91.3% of diarrheic pigs across all five established genotypes [27]; and French surveillance on Corsica detected PAstV-1 in 8.6% of samples, though this lower figure likely reflects genotype-specific targeting rather than overall prevalence [49]. In Asia, the pooled prevalence of 26.25% (95% CI: 25.41%–27.09%) [1] masks the intense heterogeneity within this vast continent. Chinese provincial studies have reported rates ranging from 17.5% in Sichuan [44] to 39.9% in Yunnan [42] and 56.4% in Guangxi [43], with a large-scale survey of over 3,200 samples from Shanghai confirming a 28.47% PAstV positivity rate [45]. Indian studies from Haryana have documented prevalence figures of 13.4–50.0% depending on age group and clinical status [18, 36, 38], while Japanese surveillance identified PAstV-2 as the predominant genotype in both domestic pigs (46.3%) and wild boars (50.0%) [24]. South American data remain sparse, but a Chilean study confirmed PAstV circulation across all 17 intensive farms sampled, with genotypes 2, 4, and 5 co-circulating on 88% of premises [28], and the first Brazilian report of neurotropic PAstV3 in piglets with polioencephalomyelitis underscores the pathogen’s expanding geographic footprint [11]. African data are particularly limited; however, whole-genome sequencing of asymptomatic piglets in Kenya and Uganda revealed novel, genetically divergent strains with nucleotide identities as low as 57.0–80.0% compared to known PoAstV references, suggesting that the true diversity in East Africa may far exceed current estimates [29]. Oceania remains a conspicuous gap in the epidemiological record, with no published prevalence data meeting inclusion criteria for the meta-analysis [1].

Temporal Trends in PAstV Prevalence

The meta-analysis by Ge et al. (2025) identified a striking temporal pattern in PAstV prevalence: the highest infection rates were observed during the 2012–2014 period (49.86%; 95% CI: 47.21%–52.51%) , after which the prevalence declined and stabilized below 30% from 2015 through 2023 [1]. This temporal decline may reflect several convergent factors. The early 2010s witnessed the widespread emergence and characterization of novel PAstV genotypes, particularly PAstV3, which was first associated with neuroinvasive disease in 2017 [25]; increased diagnostic attention during this period may have inflated detection rates. Additionally, the global porcine epidemic diarrhea virus (PEDV) pandemic of 2013–2014 prompted intensified biosecurity and surveillance measures on many farms, which may have concurrently reduced PAstV transmission [1, 45]. However, the persistence of prevalence below 30% into the 2020s suggests that PAstV has established endemic equilibrium in most swine populations, with periodic outbreaks driven by the introduction of novel recombinants or waning maternal immunity in nursery pigs [1, 19, 41]. Phylodynamic analysis of PAstV3 estimates that the most recent common ancestor (tMRCA) of this genotype emerged around the year 1660, and that the effective population size has been continuously expanding over time, indicating a long history of endemic circulation punctuated by recent evolutionary radiation [4].

Diagnostic and Sampling Modality Effects

One of the most methodologically significant findings of the meta-analysis is the substantial discrepancy in prevalence estimates based on sample type. The prevalence in non-fecal samples (43.09%; 95% CI: 41.05%–45.15%) was significantly higher than in fecal samples (22.92%; 95% CI: 21.87%–23.99%) [1]. This counterintuitive observation challenges the traditional view of PAstV as a purely enteric pathogen and aligns with mounting evidence of extra-intestinal dissemination. PAstV RNA has been detected in central nervous system tissue [8, 11, 15, 17, 25], respiratory tract specimens [37, 50], and serum [43], indicating that viremia and systemic infection occur with appreciable frequency. The higher detection rate in non-fecal samples likely reflects the ability to target tissues where viral loads are concentrated during acute systemic infection, whereas fecal shedding may be intermittent or below detection thresholds during chronic or subclinical carriage [19, 41]. Importantly, the meta-analysis found no significant influence of detection method (conventional RT-PCR vs. real-time RT-PCR vs. nested PCR) on prevalence estimates, suggesting that the observed heterogeneity is primarily biological rather than technical [1]. This is reassuring for cross-study comparisons, although the development of more sensitive multiplex assays, such as the quadruplex RT-qPCR for PAstV, porcine sapovirus, norovirus, and rotavirus A [35], or the triplex assay for neurotropic sapeloviruses, teschoviruses, and PAstV3 [50], will continue to refine detection limits and enable more accurate burden estimation.

Age-Dependent Infection Dynamics

Age is among the most powerful determinants of PAstV prevalence, reflecting the interplay between waning maternal immunity, age-dependent exposure risk, and the development of adaptive immune responses. The meta-analysis stratified pigs into five age categories and revealed a clear pattern: the highest prevalence was observed in nursery pigs (6–10 weeks) at 63.19% (95% CI: 58.45%–67.75%) , closely followed by weaning pigs (3–6 weeks) at 60.00% (95% CI: 56.48%–63.45%) [1]. This peak coincides with the post-weaning period when maternal antibody levels have waned, pigs are subjected to the stressors of social mixing, dietary change, and transport, and intensive housing facilitates fecal-oral and possibly respiratory transmission [1, 19, 36, 41]. Finisher pigs (>10 weeks) showed a prevalence of 49.89% (95% CI: 46.59%–53.19%) , while sows (35.33%; 95% CI: 31.45%–39.37%) and suckling pigs (0–3 weeks; 31.93%; 95% CI: 30.23%–33.68%) exhibited the lowest rates [1]. The relatively high prevalence in sows is notable, as it suggests that adult animals serve as an important viral reservoir and source of horizontal transmission to piglets, even in the absence of clinical signs [1, 19].

Individual studies corroborate this age gradient with remarkable consistency. In Yunnan, China, suckling piglets had an infection rate of 62.3%, while weaned pigs showed 40.8% [42]. In Haryana, India, PAstV was detected most frequently in pigs aged 3–6 weeks (55.31% of positive samples), with the ORF2 region sequencing revealing circulation of both lineage 2 and lineage 4 strains [36]. A longitudinal cohort study of PAstV3 in a herd with neurologic disease documented peak fecal shedding at 3 weeks of age (95% of pigs positive), with detection frequency declining to 4% by 21 weeks, only to rebound to 41% at 25 weeks, suggesting periodic reactivation or reinfection [41]. This pattern of high early-life infection followed by intermittent adult shedding is characteristic of enteric RNA viruses that establish persistent infections in gut-associated lymphoid tissue [41].

Clinical Status and Subclinical Carriage

A pivotal finding with profound implications for disease control is that asymptomatic pigs exhibit a higher pooled PAstV prevalence (36.71%; 95% CI: 34.97%–38.48%) than diarrheic pigs (28.18%; 95% CI: 26.94%–29.44%) [1]. This paradoxical observation, that healthy animals are more likely to test positive than those with enteric disease, underscores the predominantly subclinical nature of PAstV infection and the importance of inapparent carriers in viral maintenance. Studies from Slovakia reported PAstV in 94.4% of clinically healthy pigs versus 91.3% of diarrheic animals, with no significant difference between groups [27]. Similarly, in India, prevalence in non-diarrheic pigs (16.32%) was nearly identical to that in diarrheic pigs (16.53%) [38]. The absence of a clear association between PAstV detection and clinical diarrhea has led several authorities to question the virus’s role as a primary enteropathogen, instead suggesting that it acts as a commensal or opportunistic pathogen whose pathogenic potential is realized only in the context of co-infection, immunosuppression, or specific host genetic backgrounds [1, 27, 40].

However, the meta-analysis also documented that mixed infections are extraordinarily common , complicating the attribution of causality. In China, 75.28% of PAstV-positive diarrheic piglets were co-infected with three to five other enteric pathogens, and none were positive for PAstV alone [40]. A logistic regression model based on 3,256 Chinese fecal samples confirmed that PAstV co-infection with PEDV, porcine kobuvirus (PKoV), and porcine sapelovirus (PSV) was significantly associated with diarrheal disease, with the predominant dual-infection model PEDV/PKoV accounting for 14.18% of cases and the quadruple-infection model PEDV/PAstV/PSV/PKoV representing 46.82% of mixed infections [45]. This synergistic interplay may be mediated by PAstV-induced disruption of intestinal mucosal integrity, specifically, the NLRX1-mediated downregulation of tight junction proteins occludin and ZO-1 via the ERK/MLCK pathway [30], which facilitates invasion by other pathogens. Thus, while PAstV alone may be a mild pathogen, its contribution to the polymicrobial enteric disease complex is likely substantial.

Genotype-Specific Epidemiology

The five recognized PAstV genotypes (PAstV1–5) exhibit distinct epidemiological profiles, though comprehensive global prevalence data by genotype are limited due to the predominance of studies using broad-spectrum RdRp-targeting primers rather than genotype-specific assays. In China, a large study of diarrheic piglets from 2015–2018 found PAstV-2 to be the predominant genotype (81.48%), followed by PAstV-4 (11.11%) and PAstV-5 (7.41%) [40]. In Guangxi province, PAstV-2 (47.7%), PAstV-1 (26.2%), and PAstV-5 (21.5%) were most common across all age groups, with PAstV-1 also detected in serum samples, marking the first report of viremia for this genotype [43]. In Europe, PAstV3 appears disproportionately represented in neuropathological cases, though it is also detected in fecal samples from healthy pigs, suggesting a dual tropism [25, 46, 50]. In Japan, PAstV-2 (46.3%) and PAstV-4 (26.9%) dominated in domestic pigs, while wild boars showed a similar distribution (PAstV-2: 50%; PAstV-4: 33.3%) [24]. The co-circulation of multiple genotypes on the same farm, often 3–4 genotypes simultaneously, is a recurring observation [28, 48], underscoring the high recombinogenic potential of these viruses. Recombination events, particularly in the ORF2 capsid region, have been documented between wild boar and domestic pig strains, as well as between porcine and even deer astroviruses, facilitating antigenic diversity and immune evasion [2, 12, 23, 24].

Environmental and Wildlife Reservoirs

PAstV is not confined to domestic swine. The detection of PAstV5 in Bactrian camels in Xinjiang, China (26.44% prevalence) represents the first cross-species transmission report for this genotype and raises concerns about the potential for interspecific spread [13]. Wild boars serve as a significant reservoir: in South Korea, 0.7% of wild boar samples were PAstV-positive [22], while in Japan, the prevalence was substantially higher, with phylogenetic evidence of bidirectional viral exchange between wild and domestic populations [24]. In Chile, PAstV was confirmed in all 17 intensive farms studied, indicating that once introduced, the virus is maintained endemically [28]. Gerbil astrovirus, which clusters phylogenetically with porcine-associated astroviruses and shares up to 75% amino acid identity in RdRp with pig astroviruses, points to the existence of rodent bridge hosts that may facilitate farm-to-farm spread [47]. These ecological connections highlight the need for a One Health approach to PAstV surveillance, integrating domestic swine, wildlife, and environmental sampling to fully understand transmission networks.

Clinical Manifestations and Age-Related Susceptibility

Porcine astrovirus (PAstV) presents a remarkably complex and multifaceted clinical picture, ranging from clinically inapparent infections to severe, life-threatening neurological disease. The manifestation of disease is governed by a confluence of factors, including the specific viral genotype, the age and immunological status of the host, the presence of concurrent infections, and the route of viral entry. A critical synthesis of the available literature reveals that PAstV is not a monotypic pathogen but rather a spectrum of viruses with distinct tissue tropisms and pathogenic potentials, a reality that has only recently begun to be appreciated.

Enteric Manifestations: From Subclinical Shedding to Diarrheal Disease

The most commonly recognized clinical presentation associated with PAstV is enteric disease, typically characterized by mild to moderate diarrhea, growth retardation, and transient intestinal villus atrophy. This has been convincingly demonstrated in experimental infections. Following inoculation of gnotobiotic or colostrum-deprived piglets with PAstV type 1 (PAstV1), clinical signs are often subtle but reproducible. Piglets develop a mild, self-limiting diarrhea, with the most pronounced effects on growth performance and the morphology of the small intestinal mucosa, including villus blunting and fusion [31, 33]. These changes are associated with a measurable downregulation of critical intestinal barrier proteins, such as tight junction protein 1 and 2 and zonula occludin-1, indicating a mechanism by which the virus compromises gut integrity [33]. The disruption of the intestinal barrier may be mediated through the NLRX1-dependent activation of the ERK/MLCK signaling pathway, as demonstrated in PAstV-4 infections within Caco-2 cell models, leading to the phosphorylation of myosin light chain and subsequent downregulation of occludin and ZO-1 [30].

It is crucial, however, to contextualize these enteric signs within a broader epidemiological framework. A landmark global meta-analysis of over 45 studies revealed a critical paradox: the prevalence of PAstV in asymptomatic pigs (36.71%) significantly exceeded that in diarrheic pigs (28.18%) [1]. This finding, replicated in numerous regional studies [27, 38], underscores that PAstV is a ubiquitous enteric commensal that often persists in the host without eliciting overt clinical signs. The virus is consistently found in both healthy and diarrheic herds, and its mere detection in a fecal sample is of limited diagnostic value. For instance, in Slovakian farms, PAstV was detected in 94.4% of healthy pigs and 91.3% of pigs with diarrhea, with no statistically significant correlation to disease status [27]. Similarly, a case-control study investigating the New Neonatal Porcine Diarrhoea Syndrome (NNPDS) in Denmark found a 75% prevalence of PAstV in both diarrheic and non-diarrheic piglets, concluding that the virus did not pose a significant contribution to the syndrome [52].

The pathogenic role of PAstV in enteric disease is therefore most pronounced when it acts in concert with other pathogens. Co-infections are the rule, not the exception. In diarrheic piglets from China, over 75% of PAstV-positive samples were co-infected with three to five other porcine pathogens, with porcine enterovirus and group A rotavirus showing a statistically significant association with the occurrence of diarrhea [40]. Logistic regression models further confirm that PAstV, when co-detected with porcine epidemic diarrhea virus (PEDV) and porcine kobuvirus, is a significant contributor to clinical disease, particularly within complex multi-infection models [45]. This suggests that PAstV’s role is often that of a potentiator or co-factor, exacerbating the pathology induced by other viral agents. The biological basis for this may lie in the virus's ability to disrupt intestinal homeostasis and the mucosal immune response, thereby creating a permissive environment for other enteropathogens.

Neurological Manifestations: The Emergence of a Neurotropic Pathogen

Perhaps the most clinically significant and alarming manifestation of PAstV infection is its association with polioencephalomyelitis, a severe and often fatal neurological disease. This phenotype is almost exclusively linked to PAstV type 3 (PAstV3), a genotype now recognized as a primary neurotropic agent in swine [8, 15, 17, 25]. The clinical picture is dramatic, particularly in weaned pigs aged 25 to 35 days. Affected animals present with a range of neurological deficits, beginning with ataxia, progressive weakness, and posterior paraplegia, which can rapidly escalate to tetraparesis, lateral recumbency, and death [15, 25]. Historically, these cases were often misdiagnosed as other viral encephalitides, but the specific association with PAstV3 has been confirmed through rigorous histopathological and molecular investigations.

Upon necropsy, the hallmark lesion is non-suppurative polioencephalomyelitis, characterized by perivascular lymphoplasmacytic cuffing, multifocal gliosis, neuronal necrosis, and satellitosis, predominantly localized within the gray matter of the brainstem, cerebellum (particularly Purkinje cells), and the cervical and lumbar enlargements of the spinal cord [8, 11, 15, 25]. The detection of PAstV3 RNA within these lesions via in situ hybridization and reverse-transcription quantitative PCR (RT-qPCR) provides direct evidence of viral tropism for central nervous system (CNS) tissue [8, 15, 17]. The pathogenesis of this neuroinvasion is a subject of intense study. It is hypothesized that the virus, after initial replication in the gastrointestinal tract, gains access to the CNS via axonal transport through the enteric nervous system. This is supported by the detection of PAstV3 RNA within myenteric plexus neurons in the gut of infected piglets, which may serve as a conduit for viral spread to the spinal cord [19]. This pathway was further corroborated in an experimental reproduction of the disease, where viral RNA and antigen were detected in neurons of the cerebrum, spinal cord, and, critically, the dorsal root ganglia, confirming a pattern consistent with retrograde axonal transport [15].

The emergence of PAstV3 as a neurotropic pathogen has significant implications for animal welfare and swine health management. The high mortality rate, often eclipsing 50% in affected groups, and the lack of effective treatments have prompted calls for these viruses to be treated as serious epidemiologic threats [25]. Furthermore, the presence of a highly conserved 5' untranslated region (UTR) among neurotropic PoAstV3 strains, a region critical for translation initiation, highlights the potential for this genotype to evolve and spread [39].

Respiratory and Other Extraintestinal Manifestations

While PAstV is primarily considered an enteric pathogen, recent evidence firmly establishes its ability to cause disease outside the gastrointestinal tract, extending beyond the CNS. PAstV type 4 (PoAstV4) has been definitively linked to respiratory pathology. A landmark retrospective study utilizing RNA in situ hybridization provided the first direct association of an astrovirus with respiratory disease, detecting PoAstV4 within lesions typical of epitheliotropic viral infection in the respiratory tract of young pigs with clinical respiratory signs of unknown etiology [37]. This finding is consistent with earlier structural studies that associated PoAstV4 with respiratory disease and characterized its capsid spike protein for serological assay development [10]. The presence of PAstV RNA in nasal swabs has also been documented, with one study noting that during an outbreak of neuroinvasive PAstV3, the virus was frequently undetectable in feces but present in respiratory samples, suggesting a possible respiratory portal of entry for neurotropic strains [25, 50].

Viremia, the presence of viral RNA in the bloodstream, is another documented but poorly understood phenomenon. A large-scale study in China detected PAstV1 RNA in 5.8% of serum samples from healthy pigs, demonstrating that the virus can disseminate systemically [43]. This hematogenous spread likely provides a mechanism for the virus to reach extra-intestinal tissues, including the liver, kidney, and potentially the CNS, although viremia appears to be a rare event in PAstV3-associated neurological disease, with only 0.9% of samples testing positive in one cohort study [41]. The ability of the virus to infect and damage mitochondria, leading to the generation of reactive oxygen species and the induction of apoptosis as shown with PAstV1 and PAstV5, provides a cellular basis for the systemic pathology observed in some infections [2, 14]. This mitochondrial dysfunction may be a key driver of tissue damage beyond the gut.

Age-Related Susceptibility: A Phased Risk Profile

The clinical impact of PAstV is profoundly influenced by the age of the pig, a pattern that reflects the dynamic interplay between waning maternal immunity, the maturation of the enteric immune system, and the physiological stresses of production stages. The most comprehensive data on this topic comes from a global meta-analysis, which stratified infection rates across key production stages: suckling pigs (0-3 weeks) at 31.93%, weaning pigs (3-6 weeks) at 60.00%, nursery pigs (6-10 weeks) at 63.19%, finisher pigs (>10 weeks) at 49.89%, and sows at 35.33% [1]. This data reveals a clear "U-shaped" or, more accurately, a "peak-and-decline" curve of susceptibility.

Suckling Piglets (0-3 weeks): This age group demonstrates the lowest overall susceptibility. While they can be infected, the prevalence is relatively suppressed, a phenomenon strongly attributed to the protective effect of maternal antibodies acquired via colostrum [1]. However, when disease does occur in this cohort, it can be more severe. Colostrum-deprived piglets, lacking this passive immunity, are exquisitely susceptible, developing severe atrophic enteritis upon infection with PAstV5, which is characterized by high levels of viral shedding (up to 10^7.5 genomic copies per swab) and strong immunolabelling of enterocytes [51]. In conventional settings, infection in this age group is often subclinical, but the presence of the virus can prime the gut for more severe co-infections later on. Notably, PAstV3, the neurotropic strain, is rarely detected in piglets younger than three weeks, suggesting a need for a more mature CNS for efficient neuroinvasion or a specific developmental window for pathogenesis [19].

Weaning and Nursery Pigs (3-10 weeks): This is the period of peak susceptibility and clinical impact. The prevalence rates soar to nearly two-thirds of the population [1]. This dramatic increase coincides with the loss of maternal immunity and the profound physiological and psychological stress of weaning, which disrupts intestinal barrier function and suppresses local immune responses. It is within this age window that the most significant clinical manifestations arise. The neuroinvasive PAstV3 is almost exclusively documented in newly weaned (25-35 days old) and nursery-age pigs, with cases of polioencephalomyelitis consistently reported in this demographic across multiple continents, including Europe, the Americas, and Asia [8, 11, 15, 25]. The stress of weaning is thought to be a key trigger for the reactivation of latent PAstV3 infections, leading to CNS invasion. Similarly, the enteric form of the disease, while present across ages, is most often linked to economically impactful diarrhea in these same age groups, particularly when complicated by co-infections with rotavirus or PEDV [36, 40, 42]. The high rates of co-infection in these age groups, alongside the viral shedding data, indicate that these pigs serve as the primary reservoir and amplifier of PAstV within the herd.

Finisher Pigs and Sows: As pigs age beyond 10 weeks, infection rates decline but remain substantial. Finisher pigs and sows maintain a persistent seroprevalence, indicating endemic circulation within the herd [1]. These older animals typically act as asymptomatic shedders, contributing to the environmental contamination and transmission to younger, more susceptible cohorts. Experimental and natural infections in sows are consistently subclinical, and their role is primarily as a reservoir [19, 43]. However, the potential for recrudescence during periods of immunosuppression, such as late gestation or lactation, cannot be discounted. In a longitudinal study of a single herd, fecal shedding of PAstV3 was intermittent but could be detected in sows and finisher pigs out to 25 weeks of age, highlighting the chronic and persistent nature of the infection [41]. The high prevalence in clinically normal finisher pigs and adults underscores the need for surveillance programs that do not rely on clinical signs alone, as these animals are the silent drivers of viral transmission.

Diagnostic Approaches and Detection Methodologies

The accurate and timely detection of porcine astrovirus (PAstV) is foundational to understanding its epidemiology, pathogenesis, and economic impact on the global swine industry. The diagnostic landscape for PAstV is uniquely challenging due to the virus's profound genetic diversity, the existence of five distinct genotypes (PAstV-1 through PAstV-5) that often co-circulate within a single herd, and the predominance of asymptomatic infections that complicate clinical diagnosis [1, 27, 40]. Consequently, a multifaceted diagnostic armamentarium has evolved, ranging from conventional molecular assays for routine surveillance to advanced high-throughput sequencing for discovery and characterization. This section provides an exhaustive examination of the detection methodologies employed for PAstV, critically analyzing their principles, applications, limitations, and the biological context that governs their utility.

Molecular Detection: The Cornerstone of PAstV Diagnostics

Reverse transcription polymerase chain reaction (RT-PCR) and its quantitative variants (RT-qPCR) constitute the primary diagnostic modalities for PAstV detection, owing to their high sensitivity, specificity, and capacity for high-throughput screening. The choice of genomic target region is a critical determinant of assay performance, given the extensive sequence heterogeneity across genotypes.

Conventional and Nested RT-PCR. Early and ongoing surveillance efforts have relied heavily on conventional RT-PCR targeting highly conserved regions, most frequently the RNA-dependent RNA polymerase (RdRp) gene within ORF1b or the overlapping ORF1b/ORF2 junction [3, 18, 22, 38]. These regions are favored due to their relative conservation compared to the hypervariable capsid (ORF2) sequence, enabling broad-spectrum detection of multiple genotypes. For instance, Panghal et al. [3] screened 70 porcine fecal samples using RT-PCR targeting a partial RdRp region to identify PAstV-positive samples for subsequent whole-genome sequencing, successfully detecting PAstV-1 and PAstV-4 genotypes. Similarly, Kaur et al. [38] and Vaishali et al. [36] employed RT-PCR targeting the ORF1b/ORF2 region to screen 176 and 306 samples, respectively, revealing circulation of PAstV-2 and PAstV-4 lineages in Indian pig populations.

To enhance sensitivity, nested PCR (nPCR) assays have been developed. Pathania et al. [53] designed a nested PCR assay using outer and inner primer sets targeting the RdRp gene, achieving an analytical sensitivity of 225 femtograms and demonstrating specificity against other porcine enteric viruses such as porcine kobuvirus (PKV) and bovine rotavirus (BoRV). Field validation on 50 fecal samples from Punjab, India, confirmed its utility for routine molecular screening, detecting 12 positive samples (24%) among both diarrheic and non-diarrheic animals [53]. The increased sensitivity of nPCR is particularly advantageous for detecting low viral loads encountered in subclinical infections or in non-fecal matrices such as serum or cerebrospinal fluid (CSF).

Quantitative Real-Time RT-PCR (RT-qPCR). The advent of RT-qPCR has revolutionized PAstV diagnostics by providing absolute quantification of viral RNA, enabling kinetic studies of infection, assessment of viral shedding dynamics, and correlation with disease severity. He et al. [35] developed a quadruplex RT-qPCR assay targeting the ORF1b gene of PAstV alongside porcine sapovirus (PoSaV), porcine norovirus (PoNoV), and porcine rotavirus A (PoRVA), achieving limits of detection (LOD) as low as 138 copies/reaction for PAstV. This assay demonstrated exceptional specificity and reproducibility (intra-assay CV: 0.09–1.24%; inter-assay CV: 0.08–1.03%), and subsequent testing of 1,578 clinical samples from Guangxi, China, revealed a PAstV prevalence of 35.93% (567/1,578) with a notable 18.31% co-infection rate [35].

Specialized RT-qPCR assays have been tailored for neurotropic PAstV-3, which is increasingly recognized as a cause of polioencephalomyelitis in swine [11, 15, 17, 25]. László et al. [50] developed a one-step triplex RT-qPCR assay for simultaneous detection of neurotropic porcine sapeloviruses, teschoviruses, and type 3 PAstV, validated on 142 archived RNA samples from CNS, enteric, and nasal specimens. The assay successfully demonstrated that PAstV-3 is endemically present on most industrial swine farms in Hungary, with nasal swabs providing a non-invasive sampling alternative for surveillance [50]. Similarly, Ferreyra et al. [17] and Rawal et al. [19, 41] employed RT-qPCR targeting ORF2 to quantify PAstV-3 shedding dynamics, demonstrating peak fecal detection (95%) at 3 weeks of age and rare viremia (0.9%), suggesting that systemic spread is not a prerequisite for CNS invasion [15].

The meta-analysis by Ge et al. [1] provided critical insights into the impact of detection methods on reported prevalence. Interestingly, the subgroup analysis indicated no significant influence of detection method (RT-PCR vs. RT-qPCR vs. other molecular techniques) on the pooled prevalence estimate at the global level [1]. However, this finding must be interpreted cautiously, as the analysis aggregated data from 45 studies with heterogeneous assay designs, primer sets, and target regions. The inherent variability in analytical sensitivity across laboratories underscores the need for standardized protocols and external quality assessment programs, as advocated by the World Organisation for Animal Health (WOAH) for priority swine diseases.

Genotyping and Differentiation Strategies

Given that PAstV comprises five genetically distinct genotypes with potentially divergent pathogenicity, PAstV-3 associated with neurological disease [11, 17, 25], PAstV-5 with enteritis [9, 51], and PAstV-4 with respiratory pathology [10, 37], genotyping is essential for epidemiological surveillance and understanding genotype-specific disease associations.

Multiplex RT-PCR. Zhang et al. [48] developed a multiplex gel-based PCR assay capable of simultaneously detecting and differentiating all five PAstV genotypes in a single reaction. The assay utilized genotype-specific primers targeting the capsid (ORF2) region, producing amplicons of distinct sizes: 307 bp (PAstV-1), 353 bp (PAstV-2), 205 bp (PAstV-3), 253 bp (PAstV-4), and 467 bp (PAstV-5) [48]. Validation on 76 fecal specimens demonstrated a 47.4% detection rate, with 26.3% of samples harboring two or more genotypes. The LOD ranged from 5 × 10² copies/μL for PAstV-1 and PAstV-4 to 5 × 10³ copies/μL for PAstV-2, PAstV-3, and PAstV-5, with a >96% coincidence rate compared to monoplex assays [48]. This tool is invaluable for large-scale epidemiological surveys and for elucidating the clinical significance of mixed-genotype infections.

Probe-Based Genotyping in Real-Time Assays. While many RT-qPCR assays are designed for pan-PAstV detection, probe-based approaches can incorporate genotype-specific probes for differentiation. The quadruplex assay by He et al. [35] did not discriminate among PAstV genotypes, but its design targeting conserved ORF1b sequences ensures broad reactivity. Conversely, the triplex assay by László et al. [50] specifically targeted PAstV-3, employing a unique probe set within the ORF2 region to differentiate it from sapeloviruses and teschoviruses. This genotype-specific approach is crucial for targeted surveillance of neuroinvasive PAstV-3, which may be present at low levels in respiratory samples but cause severe neurological disease [25].

Serological Assays: Antibody Detection and Antigenicity

The development of serological tools for PAstV has been relatively limited compared to molecular methods, largely due to the challenges in producing recombinant capsid proteins that retain native antigenicity and the high genetic diversity of immunodominant epitopes.

Recombinant Capsid Spike Protein-Based ELISA. Haley et al. [10] made significant progress by designing and producing a recombinant PAstV-4 capsid spike domain for use as an antigen in serological assays. Guided by structural predictions of the full-length capsid protein, the recombinant spike was expressed in Escherichia coli, purified to homogeneity, and its crystal structure resolved at 1.85 Å resolution [10]. This recombinant protein retained antigenic epitopes found on the native capsid, enabling the successful development of an indirect ELISA for detecting PAstV-4 antibodies in swine serum. Such assays lay the groundwork for seroprevalence studies to assess the extent of past exposure and for evaluating vaccine-induced immunity.

Neutralizing Monoclonal Antibodies and Epitope Mapping. Hu et al. [7] identified an immunodominant neutralizing epitope on the PAstV-5 capsid protein through the preparation of a neutralizing monoclonal antibody (MAb), designated 6c6. The identified B-cell epitope formed an alpha-helical structure located on the external surface of the capsid spike, and MAb 6c6 demonstrated potent neutralizing activity against PAstV-5 in vitro [7]. Epitope mapping using peptide arrays and structural modeling revealed a linear motif critical for neutralization, providing a rational basis for designing peptide-based vaccines and serodiagnostic antigens. The identification of conserved antigenic epitopes across PAstV-3 strains by Ferreyra et al. [39] through in silico prediction further supports the feasibility of developing broadly reactive serological assays.

Virus Isolation and In Vitro Cultivation

The isolation of PAstV in cell culture has historically been a formidable challenge, impeding studies on viral pathogenesis, host-cell interactions, and antiviral drug screening. Recent methodological advances have begun to overcome these barriers.

Cell Lines and Culture Conditions. Several porcine cell lines have supported PAstV isolation, including PK-15 (porcine kidney) cells [2, 21, 34], LLC-PK (porcine kidney) cells [9], and Caco-2 (human intestinal) cells [30]. Du et al. [2] successfully isolated a PAstV-5 strain (PAstV5-GX2) from fecal samples by inoculating PK-15 cells and performing three successive blind passages, achieving a viral titer of 10^7.85 TCID₅₀/mL. The isolated strain induced cytopathic effects (CPE) characterized by cell rounding and detachment, and electron microscopy confirmed the presence of typical astrovirus particles approximately 28–30 nm in diameter [2]. Similarly, Li et al. [9] isolated PAstV-5 strain HNPDS-01 on LLC-PK cells from intestinal contents of diarrheic piglets, with the complete genome of 6,419 nt showing 77.2–91.1% nucleotide homology with other PAstV-5 strains.

Critical Role of Trypsin and Proteolytic Processing. A landmark discovery by Zhang et al. [5] elucidated the essential role of trypsin in PAstV infectivity and isolation. The capsid precursor protein (VP90, ~90 kDa) is synthesized intracellularly and released into the extracellular milieu, where trypsin-mediated cleavage is required for maturation into infectious virions. Trypsin cleaves VP90 into four terminal products of 25 (VP25), 27 (VP27), 30 (VP30), and 34 (VP34) kDa [5]. Critically, progeny viruses assembled from un-cleaved or incompletely processed capsid precursors were non-infectious, but infectivity could be restored by exogenous trypsin treatment. This mechanism differs from human astrovirus, which undergoes an intracellular "VP90-VP70" cleavage pathway mediated by caspases. For PAstV, intracellular caspases promote but are not required for viral release, and the mature infectious particle consists of VP27, VP30, and VP34 [5]. This finding explains the historical difficulty in isolating PAstV without trypsin supplementation and underscores the necessity of including trypsin in culture media for successful virus propagation.

Co-Infection Facilitation. Unexpectedly, co-infection with other viruses has facilitated PAstV isolation. Mi et al. [34] reported the isolation of PAstV-5 strain AH29-2014 from a clinical sample co-infected with classical swine fever virus (CSFV). The presence of CSFV significantly enhanced PAstV-5 replication in PK-15 cells, likely through suppression of the type I interferon response [34]. This observation suggests that immuno-suppressive co-infections may artificially create permissive conditions for PAstV propagation and could be exploited as a strategy for isolating fastidious strains.

Advanced Detection Platforms: ISH, CRISPR-Based Assays, and Reporter Viruses

Beyond conventional molecular and serological methods, emerging technologies are providing unprecedented insights into PAstV tropism, replication dynamics, and host-virus interactions.

In Situ Hybridization (ISH). ISH has been instrumental in localizing PAstV RNA within specific cell types and tissues, providing direct evidence of viral tropism. Rahe et al. [37] employed RNA ISH to detect PAstV-4 in respiratory tract lesions of pigs with clinical respiratory disease, demonstrating viral RNA within epitheliotropic lesions in 85 of 117 pigs (72.6%). This was the first study to definitively associate an astrovirus with respiratory pathology, providing strong evidence for a causal relationship [37]. Similarly, Ferreyra et al. [15] used ISH to detect PAstV-3 RNA in neurons of the cerebrum, spinal cord, dorsal root ganglion, and nerve roots of experimentally infected pigs, suggesting axonal transport as a route of CNS invasion. Rawal et al. [19] detected PAstV-3 in myenteric plexus neurons, elucidating a potential pathway for enteric-to-neural spread.

CRISPR-Cas9-Based Functional Screening. Luo et al. [32] employed a genome-wide CRISPR-Cas9 loss-of-function screen in porcine epithelial cells to identify host factors essential for PAstV entry. This forward genetic approach identified Annexin A1 (ANXA1) as a critical entry cofactor that directly interacts with the acidic C-terminal domain of the PAstV ORF2 capsid protein. Genetic ablation of ANXA1 significantly reduced viral binding and early RNA signals, while pharmacological blockade with neutralizing antibodies or re-expression restored susceptibility [32]. Surface plasmon resonance confirmed a direct protein-protein interaction between ANXA1 and the capsid, with imaging studies showing co-localization of ANXA1 with incoming viral particles at the cell surface. Of note, ANXA1 deficiency did not affect infection by other swine viruses tested, indicating selective dependency for PAstV [32]. This discovery not only identifies a therapeutic target but also provides a mechanistic basis for developing cell-based entry assays for high-throughput drug screening.

Recombinant Reporter Viruses. Reverse genetics systems have enabled the construction of recombinant PAstV expressing fluorescent reporter proteins. Du et al. [54] successfully inserted the iLOV (improved light-oxygen-voltage) fluorescent gene into the hypervariable

Co-Infections and the Role of PAstV in Enteric Disease

The etiological landscape of porcine enteric disease is characterized by a complex interplay of viral, bacterial, and parasitic agents, with co-infections representing the rule rather than the exception in commercial swine operations. Within this polymicrobial milieu, porcine astrovirus (PAstV) occupies a particularly enigmatic position. Despite its near-ubiquitous detection in swine herds globally, the precise contribution of PAstV to clinical enteric disease remains a subject of intense investigation, largely because its pathogenic potential is profoundly modulated by the presence of co-infecting pathogens. The high prevalence of PAstV, often exceeding 50% in asymptomatic populations [1, 27], has historically confounded efforts to establish a direct causal link between infection and diarrhea. However, a growing body of evidence, derived from experimental infections, epidemiological modeling, and metagenomic analyses, is elucidating a nuanced role for PAstV as a critical component of the enteric disease complex, acting as a primary pathogen under specific conditions and as a synergistic co-factor in others.

The Ubiquity of Mixed Infections: Epidemiological Evidence

The epidemiological data overwhelmingly demonstrate that PAstV is rarely found in isolation, particularly in clinically affected animals. A landmark meta-analysis encompassing 45 studies across three continents reported a global pooled prevalence of 28.19%, but critically, the prevalence in asymptomatic pigs (36.71%) was paradoxically higher than in diarrheic pigs (28.18%) [1]. This counterintuitive finding underscores the necessity of examining the co-infection context. In diarrheic piglets in China, a study found that 75.28% (67/89) of PAstV-positive samples were co-infected with three to five other porcine pathogens, and remarkably, none of the samples were positive for PAstV alone [40]. This suggests that PAstV-driven diarrhea is frequently a consequence of synergistic interactions with other enteric viruses. Statistical analyses from this cohort identified a significant association between PAstV-induced diarrhea and co-infection with porcine enterovirus (PEV) and group A rotavirus (GARV) [40]. Similarly, in Sichuan Province, China, only 13.6% of PAstV-positive samples were single infections, while the remainder were co-infected with porcine epidemic diarrhea virus (PEDV), porcine rotavirus A (PRoVA), or both [44]. These patterns are not geographically restricted; in Haryana, India, mixed infections were found in 77 of 306 diarrheic samples, with PAstV being the most frequently detected virus (50%), often alongside porcine circovirus 2 (PCV-2, 35.3%) and PRV-A (10.6%) [36]. The development of advanced diagnostic tools, such as a quadruplex RT-qPCR for PAstV, porcine sapovirus (PoSaV), porcine norovirus (PoNoV), and porcine rotavirus A (PoRVA), has confirmed the high incidence of mixed infections (18.31%) in clinical settings, providing a robust platform for dissecting these complex interactions [35].

Synergistic Mechanisms: Immunomodulation and Enhanced Replication

The mechanistic basis for the frequent co-detection of PAstV with other viruses lies in its ability to manipulate the host's antiviral defenses. PAstV has evolved sophisticated strategies to subvert the type I interferon (IFN) response, a cornerstone of the innate immune system. The nonstructural protein nsP1a/4 of PAstV1 has been shown to antagonize IFN-β production by targeting the key signaling molecules MAVS and IRF3 in the RIG-I-like receptor (RLR) pathway [6]. This immunosuppressive effect creates a permissive environment for co-infecting pathogens. A compelling example of this synergy is the relationship between PAstV5 and classical swine fever virus (CSFV). The first successful isolation of a PAstV5 strain was achieved from a CSFV-infected tissue sample, and subsequent mechanistic studies revealed that CSFV co-infection significantly enhanced PAstV5 replication in PK-15 cells by suppressing beta interferon production [34]. This finding demonstrates a direct virological synergy where one virus (CSFV) actively facilitates the replication of another (PAstV5) through immunomodulation.

Conversely, PAstV itself can be a beneficiary of this dynamic. The virus induces oxidative stress in infected cells, characterized by increased mitochondrial reactive oxygen species (ROS) production and downregulation of antioxidant factors like Nrf2 and HO-1 [2]. This ROS generation, in turn, facilitates PAstV replication [2]. Co-infecting pathogens that also induce oxidative stress could theoretically amplify this effect, creating a feed-forward loop that enhances PAstV replication and, consequently, its pathogenic potential. Furthermore, the PAstV nsP1a/3 protein possesses a 3C-like serine protease activity that mediates mitochondrial apoptosis and cleaves MAVS, further antagonizing the type I IFN response and facilitating viral replication [14]. This dual-action mechanism, inducing cell death while simultaneously dismantling antiviral signaling, provides a powerful means for PAstV to potentiate the pathogenicity of co-infecting agents.

The Enteric Disease Complex: PAstV as a Primary and Contributory Pathogen

While PAstV is often considered a mild or subclinical pathogen, experimental infections have definitively established its capacity to cause enteric disease. Inoculation of gnotobiotic or colostrum-deprived piglets with PAstV1 and PAstV5 strains has consistently resulted in mild diarrhea, growth retardation, and histopathological lesions including villous atrophy, fusion, and damage to the small intestinal mucosa [9, 33, 51]. The PAstV5 strain HNPDS-01, for instance, caused mild diarrhea and significantly altered the cecal microbiota, with a downregulation of beneficial bacteria like Faecalibacterium, Bacteroides, Lactobacillus, and Prevotella, and an upregulation of harmful bacteria such as Subdoligranulum [9]. This disruption of the gut microbiome is a critical pathogenic mechanism, as dysbiosis can perpetuate inflammation and reduce resistance to colonization by other pathogens.

The role of PAstV becomes more pronounced in the context of co-infection with highly virulent pathogens like PEDV. Logistic regression models analyzing 3,256 fecal samples from China identified PAstV as one of the pathogens most closely related to porcine diarrhea, and the predominant mixed-infection models frequently involved PEDV with PAstV, porcine kobuvirus (PKoV), and porcine sapelovirus (PSV) [45]. The dominant quadruple-infection model was PEDV/PAstV/PSV/PKoV (46.82%) [45]. This suggests that PAstV, while perhaps not the primary driver of severe clinical signs in a PEDV outbreak, contributes to the overall disease burden and may prolong the duration of diarrhea or increase the severity of lesions. The disruption of intestinal mucosal function by PAstV4, mediated through the NLRX1/ERK/MLCK pathway leading to downregulation of tight-junction proteins (occludin and ZO-1) and MUC-2 [30], provides a mechanistic explanation for this synergy. By compromising the intestinal barrier, PAstV infection can facilitate the translocation of other pathogens or their toxins, exacerbating the clinical outcome.

Zoonotic Considerations and Public Health Implications

The high prevalence of PAstV in swine populations, coupled with its frequent co-detection with other enteric viruses, raises important questions about zoonotic potential and food safety. Astroviruses are known to cross species barriers, and the detection of PAstV5 in Bactrian camels in China suggests a broader host range than previously appreciated [13]. Phylogenetic analyses have shown that some PAstV strains cluster closely with human astroviruses, and the codon usage patterns of PAstV indicate a similarity to that of their animal hosts, which may facilitate cross-species transmission [16]. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have emphasized the need for a "One Health" approach to monitor emerging zoonotic pathogens in livestock. The detection of human enteric viruses, including astrovirus, in porcine stool samples in South Korea [26] underscores the bidirectional flow of viruses at the human-animal interface. While direct evidence of PAstV transmission to humans is lacking, the high genetic diversity and recombination potential of the virus [21, 23, 24], combined with its ability to co-infect with other zoonotic agents like hepatitis E virus, warrant continuous surveillance. The World Organisation for Animal Health (WOAH) recognizes the economic impact of enteric diseases on the swine industry, and understanding the role of PAstV within the co-infection paradigm is essential for developing effective control strategies, including vaccination and biosecurity measures, to mitigate both economic losses and potential public health risks.

Surveillance, Control Strategies, and Future Directions

Current Surveillance Infrastructure and Epidemiological Gaps

The global surveillance landscape for porcine astrovirus (PAstV) is characterized by profound heterogeneity, fragmented data collection, and a predominant reliance on cross-sectional studies that fail to capture the dynamic, often subclinical, nature of infection. The meta-analysis by Ge et al. [1] provides the most comprehensive synthesis to date, estimating a global pooled prevalence of 28.19%, yet this figure belies striking continental disparities: North America exhibits a staggering 63.24% prevalence, while Asia and Europe report 26.25% and 36.19%, respectively [1]. These discrepancies likely reflect differential surveillance intensity, diagnostic methodologies, and husbandry practices rather than true biological variation. Critically, the meta-analysis reveals that prevalence in asymptomatic pigs (36.71%) paradoxically exceeds that in diarrheic pigs (28.18%), a finding that fundamentally challenges the traditional sentinel-based surveillance paradigm that relies on clinical case reporting [1]. This asymptomatic carriage, particularly pronounced in nursery pigs (63.19% prevalence) [1], establishes PAstV as an insidious, enzootic pathogen circulating largely undetected within herds, perpetuating transmission chains that evade conventional veterinary oversight.

The neurotropic potential of PAstV, specifically genotype 3 (PAstV3), introduces a layer of complexity that current surveillance architectures are ill-equipped to address. Porcine astrovirus type 3 has been definitively associated with polioencephalomyelitis in swine across multiple continents, including North America [15, 17], Europe [25], Asia [8], and South America [11]. The seminal experimental reproduction of PoAstV3-associated CNS disease by Ferreyra et al. [15] demonstrated that viral RNA is detectable within the central nervous system (CNS) by reverse transcription quantitative PCR (RT-qPCR) and in situ hybridization (ISH) in neurons of the cerebrum, spinal cord, and dorsal root ganglia, with viral dissemination likely occurring via axonal transport [15]. Critically, Rawal et al. [41] documented that while fecal shedding of PAstV3 peaks at 3 weeks of age (95% detection), viremia is exceedingly rare (0.9%), and the virus is frequently undetectable in feces by the time neurological signs manifest [41]. This temporal disconnect between enteric shedding and CNS pathology renders traditional fecal-based surveillance programs entirely inadequate for detecting neuroinvasive strains. Indeed, Boros et al. [25] reported that in Hungarian outbreaks of neuroinvasive astrovirus, viral RNA was generally undetectable in feces but present in respiratory samples, suggesting an alternative route of entry and dissemination that bypasses standard diagnostic algorithms. The detection of PAstV3 in the myenteric plexus neurons by Rawal et al. [19] further elucidates a potential route of neuroinvasion from the gastrointestinal tract, yet this pathway remains unmonitored in routine surveillance.

Furthermore, existing surveillance systems overwhelmingly focus on domestic swine populations, largely ignoring the critical role of wildlife reservoirs in viral maintenance and evolution. The detection of PAstV5 in Bactrian camels in China by Zhang et al. [13] marks the first report of this genotype outside of swine, with a prevalence of 26.44% (69/261) in camel anal swabs, suggesting active cross-species transmission. Similarly, Nie et al. [47] identified a novel gerbil astrovirus (GeAstV) that shares 75.07% amino acid identity with a porcine astrovirus in the RdRp region, exhibiting apparent recombination and potential cross-species transmission events. The metagenomic survey of Japanese wild boars by Mizuno et al. [24] revealed that wild boar populations harbor PoAstV-2, -4, and -5, with some strains exhibiting high nucleotide identity to domestic Japanese strains, while others cluster with foreign porcine strains, indicating bidirectional viral flow at the wildlife-domestic interface. This genetic exchange is further evidenced by intragenotype recombination events detected among wild boar and domestic pig strains [24]. These findings underscore a fundamental surveillance blind spot: the absence of coordinated, longitudinal sampling of wildlife populations, particularly wild boar, which serve as both reservoirs and evolutionary crucibles for novel recombinant strains with unpredictable pathogenic potential.

Diagnostic Tool Development and Molecular Epidemiology as Surveillance Pillars

The development and refinement of molecular diagnostic assays represent the cornerstone of effective PAstV surveillance, yet the field remains fragmented, with no universally adopted gold standard. Ge et al. [1] demonstrated that detection method (conventional RT-PCR, real-time RT-qPCR, or nested PCR) did not significantly influence reported prevalence, suggesting that assay sensitivity alone is not the primary driver of epidemiological variation. However, sample type exerted a profound effect: non-fecal samples (serum, tissues) exhibited a prevalence of 43.09% compared to 22.92% in fecal samples [1], highlighting the importance of sampling beyond the enteric tract for comprehensive surveillance, particularly for neurotropic strains.

Recent advances have expanded the diagnostic armamentarium significantly. He et al. [35] developed a quadruplex RT-qPCR targeting the ORF1 gene of PoAstV alongside porcine sapovirus, norovirus, and rotavirus A, achieving limits of detection (LODs) of 138 copies/reaction for PAstV with no cross-reactivity against other swine viruses [35]. This multiplex approach is particularly valuable given the high co-infection rates documented in clinical settings; Li et al. [45] reported that PAstV is a dominant component of mixed infections, with the quadruple-infection model of PEDV/PAstV/PSV/PKoV accounting for 46.82% of cases in Shanghai [45]. The triplex RT-qPCR assay developed by László et al. [50] specifically targets neurotropic pathogens, including PAstV3, sapeloviruses, and teschoviruses, and has been validated on nasal swab samples, demonstrating that PAstV3 is widespread and endemically present in Hungarian swine farms [50]. This assay's applicability to nasal samples is particularly relevant given the potential respiratory route of neuroinvasion [25].

For resource-limited settings, simpler yet robust assays offer practical alternatives. Pathania et al. [53] developed a nested PCR (nPCR) targeting the RdRp gene with a sensitivity of 225 femtograms, capable of detecting PAstV in both diarrheic and non-diarrheic fecal samples. The duplex RT-PCR developed by Pathania et al. [55] enables concurrent detection of PAstV and porcine kobuvirus with LODs of 2.74 ng and 30 fg, respectively, facilitating high-throughput screening in endemic regions. The multiplex gel-based PCR assay designed by Zhang et al. [48] can simultaneously differentiate all five PAstV genotypes (PAstV1–5) with fragment sizes of 307, 353, 205, 253, and 467 bp, respectively, achieving an LOD of 5 × 10² copies/μL for PAstV1 and PAstV4. This genotyping capability is essential for surveillance given the distinct pathogenic profiles of each genotype: PAstV1 is primarily enteric [33], PAstV3 is neurotropic [15, 17, 25], PAstV4 is associated with respiratory pathology [37], and PAstV5 causes atrophic enteritis [51].

The integration of next-generation sequencing (NGS) and metagenomics into surveillance frameworks has revolutionized our understanding of PAstV genetic diversity and evolution. The study of Japanese wild boars and domestic pigs by Mizuno et al. [24] used metatranscriptome analysis to recover 79 near-complete genomes, revealing that PoAstV-2 (31/67) and PoAstV-4 (18/67) are predominant in domestic pigs, mirroring the pattern in wild boars. Crucially, NGS detects recombination events that conventional genotyping may miss; Chen et al. [21] identified a novel recombinant PAstV4 strain (Ahast) in Anhui, China, with multiple recombination breakpoints, while Li et al. [9] documented recombination in the ORF2 region (4,444–5,323 nt) of PAstV5-HNPDS-01. The study of East African smallholder pig farms by Amimo et al. [29] used whole-genome sequencing to identify novel PoAstV2 and PoAstV4 strains sharing only 57.0–80% nucleotide identity with known strains, indicating that novel genotypes likely circulate undetected in regions with limited sequencing capacity. These findings collectively argue for the routine implementation of NGS-based surveillance, particularly in regions with high pig density and limited biosecurity, to monitor the emergence of recombinant and potentially more virulent strains.

Ecology of Transmission and Environmental Surveillance

Understanding PAstV transmission dynamics is critical for designing effective control strategies, yet the ecology of this virus remains poorly characterized. The longitudinal study by Rawal et al. [41] on a herd with PoAstV3-associated neurologic disease provides the most detailed picture to date: fecal shedding frequency varied dramatically by age, peaking at 95% (61/64) at 3 weeks of age, declining to 4% (2/47) at 21 weeks, before rebounding to 41% (19/46) at 25 weeks. This pattern suggests that maternal antibody waning permits early infection, whereas later rebounds may reflect re-infection from environmental contamination or reactivation of latent virus. Crucially, environmental sampling revealed that pens and feeders had a high rate of detection at most time points [41], indicating that fomites play a substantial role in transmission. The detection of high viral loads in oral fluid (75–100% positive at each time point) [41] further suggests that communal feeding and drinking sources serve as efficient transmission vehicles, particularly in wean-to-finish operations where pigs are housed in large groups.

The high prevalence of PAstV in asymptomatic pigs, as documented by Ge et al. [1], Šalamúnová et al. [27], and Stamelou et al. [46], poses a fundamental challenge for control: asymptomatic shedders maintain infection pressure within herds without triggering clinical suspicion. Stamelou et al. [46] detected PAstV in 95.4% of pooled fecal samples from 28 Greek swine farms, with PAstV3 being the predominant haplotype (91.2%), demonstrating that endemic circulation is nearly universal in some regions. The detection of PAstV in 75% of Danish piglets with neonatal diarrhea by Goecke et al. [52], with 69.8% of these being PAstV3, further illustrates that high infection rates can coexist with ambiguous clinical significance, complicating efforts to attribute causation.

Age-stratified surveillance data consistently identify nursery pigs (6–10 weeks) as the highest-risk demographic, with a prevalence of 63.19% [1]. This age predilection coincides with the waning of maternally derived immunity and the stress of weaning and social mixing, which may trigger both enhanced susceptibility and increased shedding. The finding that weaning pigs (3–6 weeks) exhibit a prevalence of 60.00% [1] further underscores the peripartum and early post-weaning period as a critical window for targeted interventions. Conversely, suckling pigs (0–3 weeks) show the lowest rate (31.93%) [1], likely due to protection from maternal antibodies, while sows (35.33%) [1] serve as potential reservoirs that contaminate farrowing environments.

Current Control Strategies: Limitations and Opportunities for Intervention

No licensed vaccine or specific antiviral therapy currently exists for PAstV, rendering control efforts reliant on generic biosecurity measures that are inconsistently applied and often inadequate for a virus with such pervasive environmental contamination. The demonstrated trypsin-dependent maturation of PAstV capsid, as elucidated by Zhang et al. [5], presents a unique vulnerability: the capsid precursor VP90 (~90 kDa) must be cleaved by extracellular trypsin into VP25, VP27, VP30, and VP34 to produce infectious virions. This requirement for exogenous protease activity suggests that the gastrointestinal microenvironment, particularly the presence of pancreatic trypsin in the small intestine, is a critical determinant of viral infectivity. The inhibition of trypsin activity, potentially through dietary interventions or protease inhibitors, could theoretically reduce infectious virus production, though the ubiquitous nature of trypsin in the porcine gut makes this approach challenging.

The identification of immunodominant neutralizing epitopes offers a rational pathway for vaccine development. Hu et al. [7] prepared the first neutralizing monoclonal antibody (6c6) against the PAstV5 capsid protein and identified an alpha-helical B-cell epitope located on the external surface of the three-dimensional capsid structure. This epitope exhibited strong neutralizing activity, providing a potential template for peptide-based vaccines. Similarly, Ferreyra et al. [39] predicted two conserved antigenic epitopes matching the 3′ termini of VP27 of PoAstV3 USA strains, which could aid in the design of vaccine components. The structural determination of the PoAstV4 capsid spike protein at 1.85 Å resolution by Haley et al. [10] provides atomic-level information for rational vaccine antigen design, demonstrating that the recombinant spike protein retains antigenic epitopes found on native virions and can be used for serological assays [10].

However, vaccine development faces substantial hurdles. The high genetic diversity across five genotypes and multiple subtypes, with intergenotype ORF2 nucleotide identities as low as 59.7–69.8% [4], suggests that a monovalent vaccine may provide limited cross-protection. Furthermore, the capsid protein VP90 undergoes complex proteolytic processing involving trypsin [5] and potentially intracellular caspases, and the final mature virion contains three distinct cleavage products (VP34, VP30, and VP27) rather than a single capsid species [5]. This structural complexity complicates the design of recombinant protein-based vaccines that accurately recapitulate native antigenic conformations. The finding that trypsin treatment of non-infectious progeny viruses can restore infectivity [5] implies that improperly processed capsid precursors may still elicit immune responses, but their protective efficacy against fully processed virions remains uncertain.

The potential for antiviral drug development has been significantly advanced by recent discoveries in PAstV molecular biology. Du et al. [2] demonstrated that PAstV5 infection induces mitochondrial reactive oxygen species (ROS) production while downregulating the antioxidant factors Nrf2 and HO-1, and that ROS enhances viral replication. This suggests that antioxidant therapies, such as N-acetylcysteine (NAC) or specific Nrf2 agonists, could represent a host-directed antiviral strategy. More directly, the 3C-like serine protease activity of nsP1a/3, as characterized by Du et al. [14], mediates mitochondrial apoptosis, MAVS cleavage, and suppression of the type I interferon response. Importantly, treatment with a serine protease inhibitor markedly decreased PAstV replication [14], identifying the nsP1a/3 protease as a high-priority drug target that could be exploited using structure-based inhibitor design.

The discovery of Annexin A1 (ANXA1) as an entry cofactor for PAstV by Luo et al. [32] opens another therapeutic avenue. Genetic ablation or pharmacological/antibody blockade of ANXA1 reduced viral binding, early RNA synthesis, and progeny production, while re-expression restored susceptibility. Surface plasmon resonance confirmed a direct interaction between ANXA1 and the acidic C-terminal domain of the ORF2 capsid protein [32]. This interaction could be targeted using small molecules or monoclonal antibodies that block ANXA1-capsid binding, potentially preventing viral entry across multiple PAstV genotypes if the C-terminal domain is conserved. The genome-wide CRISPR screen that identified ANXA1 also provides a template for identifying additional host dependency factors that could serve as antiviral targets.

The development of reverse genetics systems and reporter viruses, as pioneered by Du et al. [54], represents a milestone for both basic research and applied drug screening. The insertion of the improved light-oxygen-voltage (iLOV) gene into the hypervariable region (HVR) of ORF1a produced a stable recombinant reporter virus that maintained green fluorescence after 15 passages in cell culture [54]. This reporter system enables real-time visualization of PAstV infection in living cells and could be adapted for high-throughput screening of compound libraries. The identification of five tolerable insertion sites within ORF1a, including the predicted coiled-coil structures and VPg [54], further expands the toolkit for generating tagged viruses suitable for tracking viral protein localization and interactions during infection.

Immunomodulatory Strategies and Understanding Immune Evasion

The intricate interplay between PAstV and the host innate immune system provides both challenges for viral clearance and opportunities for therapeutic intervention. Dong et al. [6] demonstrated that the PAstV1 nsP1a/4 protein antagonizes interferon beta (IFN-β) production by interacting with MAVS and IRF3, thereby impeding the RIG-I/MDA5 signaling cascade. This immune evasion mechanism is critical for establishing productive infection, as the RIG-I and MDA5 pathways are essential for PAstV1-induced IFN-β production [31]. Knockdown of RIG-I and MDA5 decreased IFN-β expression and, paradoxically, increased viral loads, but also enhanced PAstV1 infectivity [31], suggesting that a balanced IFN response can exert both antiviral and, under certain conditions, proviral effects.

The mitochondrial-centric nature of PAstV pathogenesis is increasingly apparent. Tao et al. [30] showed that PAstV4 infection upregulates NLRX1, a mitochondrial NOD-like receptor, which triggers mitophagy and disrupts intestinal mucosal function via the ERK/MLCK pathway, leading to downregulation of tight-junction proteins (occludin, ZO-1) and MUC-2 expression. Silencing NLRX1 or treating with the mitophagy inhibitor 3-MA inhibited PAstV4 replication and restored tight-junction integrity [30]. This suggests that NLRX1 could be a druggable target; inhibitors of NLRX1 activation or downstream ERK signaling (e.g., PD98059) might preserve intestinal barrier function and reduce viral replication. The proteomic analysis by Tao et al. [12] further identified ATG7 as a key mediator in the crosstalk between autophagy and apoptosis during PAstV4 infection, with mitochondria appearing as a primary target of viral manipulation [12].

The mitochondrial apoptosis pathway is directly exploited by PAstV1 through the nsP1a/3 3C-like serine protease, which localizes to mitochondria, induces MAVS cleavage, and triggers caspase-9 and caspase-3 activation [14]. The apoptosis inhibitor Z-VAD-FMK reduced viral replication, while the apoptosis inducer ABT-263 enhanced it at later stages [14], indicating that PAstV co-opts programmed cell death to facilitate release and dissemination. Importantly, the serine protease activity of nsP1

References

[1] Ge X, Li Y, Zhao F, Ma X, Li J, Jiang Y, et al.. Global prevalence of Porcine Astrovirus: A systematic review and meta-analysis.. Preventive Veterinary Medicine. 2025. DOI: https://doi.org/10.1016/j.prevetmed.2025.106465

[2] Du Y, Qin Y, Feng X, Luo Y, Lv Y, Song S, et al.. Isolation and identification of a new porcine astrovirus 5 demonstrated that oxidative stress enhances porcine astrovirus replication. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-04939-x

[3] Panghal R, Kumar P, Minhas SK, Mehtani R, Kalonia S, Sheoran D, et al.. Whole genome sequencing and molecular characterization of porcine astrovirus from Haryana, India.. Infection, Genetics and Evolution. 2025. DOI: https://doi.org/10.1016/j.meegid.2025.105816

[4] Wu Q, Jiang J, Li Q, Xiao C, Chen B, Sun M, et al.. Prevalence, Genetics, and Evolution of Porcine Astrovirus 3 in China. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/3170440

[5] Zhang W, Pan L, Huang Y, Dong Q, Liu T, Du Y, et al.. Proteolytic processing of the capsid precursor by trypsin is essential for porcine astrovirus infectivity and isolation in vitro.. Veterinary Microbiology. 2025. DOI: https://doi.org/10.1016/j.vetmic.2025.110598

[6] Dong Q, Luo Y, Pan Y, Liu Y, Qin L, Kang O, et al.. The C-terminal nsP1a protein of porcine astrovirus antagonizes interferon beta production by targets MAVS and IRF3 signaling.. Veterinary Microbiology. 2025. DOI: https://doi.org/10.1016/j.vetmic.2025.110530

[7] Hu Y, Li Z, Hao C, Lu H, Xing Y, Liu K, et al.. Identification of an immunodominant neutralizing epitope of porcine astrovirus type 5 capsid protein. Virologica Sinica. 2025. DOI: https://doi.org/10.1016/j.virs.2025.03.003

[8] Park J, Jeong C, Chae S, Yang M, Oh B, Lee S, et al.. Porcine Astrovirus Infection in Brains of Pigs in Korea. Viruses. 2024. DOI: https://doi.org/10.3390/v16091372

[9] Li Z, Wu X, Zhang Y, Li Q, Gao J, Hu Y, et al.. Isolation and Pathogenicity of a Chinese Porcine Astrovirus Type 5 Strain HNPDS-01 and Its Influence on Cecum Microbiota in Piglets. Transboundary and Emerging Diseases. 2024. DOI: https://doi.org/10.1155/2024/5777097

[10] Haley DJ, Lanning S, Henricson KE, Mardirossian AA, Cirillo I, Rahe MC, et al.. Structure and Antigenicity of the Porcine Astrovirus 4 Capsid Spike. Viruses. 2024. DOI: https://doi.org/10.3390/v16101596

[11] Yasumitsu CY, Agnol AMD, Xavier AAC, Silva FHP, Callegari M, Pereira UdP, et al.. Porcine astrovirus 3 RNA in the central nervous system of weaned pigs with neurologic disease and polioencephalomyelitis in Brazil.. Microbial Pathogenesis. 2024. DOI: https://doi.org/10.1016/j.micpath.2024.106917

[12] Tao J, Li B, Cheng J, Shi Y, Qiao C, Lin Z, et al.. Genomic Divergence Characterization and Quantitative Proteomics Exploration of Type 4 Porcine Astrovirus. Viruses. 2022. DOI: https://doi.org/10.3390/v14071383

[13] Zhang Y, Ding X, Tao X, Tuohuti N, Wang X, Maimaiti A, et al.. Viral Metagenomic Analysis Reveals High Prevalence of Dromedary Camel Bocavirus and Porcine Astrovirus in Bactrian Camel Intestinal Tissue. Viruses. 2026. DOI: https://doi.org/10.3390/v18030302

[14] Du Y, Lv Y, Feng X, Luo Y, Wei X, Shao S, et al.. The 3C-like serine protease activity of porcine astrovirus nsP1a/3 mediates mitochondrial apoptosis and MAVS cleavage to facilitate viral replication and antagonize type I interferon response.. PLoS Pathogens. 2026. DOI: https://doi.org/10.1371/journal.ppat.1013987

[15] Ferreyra F, Arruda PH, Bradner L, Harmon K, Zhang M, Gimenez-Lirola L, et al.. Experimental porcine astrovirus type 3-associated polioencephalomyelitis in swine. Veterinary Pathology-Supplement. 2021. DOI: https://doi.org/10.1177/03009858211025794

[16] Wu H, Bao Z, Mou C, Chen Z, Zhao J. Comprehensive Analysis of Codon Usage on Porcine Astrovirus. Viruses. 2020. DOI: https://doi.org/10.3390/v12090991

[17] Ferreyra FSM, Bradner L, Burrough ER, Cooper V, Derscheid R, Gauger P, et al.. Polioencephalomyelitis in Domestic Swine Associated With Porcine Astrovirus Type 3. Veterinary Pathology-Supplement. 2020. DOI: https://doi.org/10.1177/0300985819875741

[18] Kaur R, Kumar P, Jindal N, Minhas SK, Prakash AK, Dahiya S, et al.. Molecular Detection and Characterization of Porcine Astrovirus on the basis of Partial ORF1b/ORF2 Region. . 2021. DOI: https://doi.org/10.21203/rs.3.rs-1183359/v1

[19] Rawal G, Ferreyra FSM, Macedo NR, Bradner LK, Harmon KM, Mueller A, et al.. Detection and Cellular Tropism of Porcine Astrovirus Type 3 on Breeding Farms. Viruses. 2019. DOI: https://doi.org/10.3390/v11111051

[20] Du Y, Ji C, Liu T, Zhang W, Fang Q, Dong Q, et al.. Identification of a novel protein in porcine astrovirus that is important for virus replication.. Veterinary Microbiology. 2021. DOI: https://doi.org/10.1016/j.vetmic.2021.108984

[21] Chen X, He Y, Li W, Kalim U, Xiao Y, Yang J, et al.. Identification and Characterization of a Novel Recombinant Porcine Astrovirus from Pigs in Anhui, China. Polish Journal of Microbiology. 2020. DOI: https://doi.org/10.33073/pjm-2020-051

[22] Lee M, Jeoung H, Park H, Lim J, Song J, An D. Phylogenetic analysis of porcine astrovirus in domestic pigs and wild boars in South Korea. Virus genes. 2012. DOI: https://doi.org/10.1007/s11262-012-0816-8

[23] Lan D, Ji W, Shan T, Cui L, Yang Z, Yuan C, et al.. Molecular characterization of a porcine astrovirus strain in China. Archives of Virology. 2011. DOI: https://doi.org/10.1007/s00705-011-1050-8

[24] Mizuno S, Teshima N, Yokota T, Khin STMM, Takemae H, Oi T, et al.. Genetic diversity and evolutionary relationships of porcine astroviruses from wild boars and domestic pigs in Japan.. Infection, Genetics and Evolution. 2025. DOI: https://doi.org/10.1016/j.meegid.2025.105875

[25] Boros Á, Albert M, Pankovics P, Bíró H, Pesavento P, Phan T, et al.. Outbreaks of Neuroinvasive Astrovirus Associated with Encephalomyelitis, Weakness, and Paralysis among Weaned Pigs, Hungary. Emerging Infectious Diseases. 2017. DOI: https://doi.org/10.3201/eid2312.170804

[26] Yeo D, Hossain MI, Jung S, Wang Z, Seo Y, Woo S, et al.. Prevalence and phylogenetic analysis of human enteric emerging viruses in porcine stool samples in the Republic of Korea. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.913622

[27] Šalamúnová S, Jacková A, Mandelík R, Novotný J, Vlasakova M, Vilcek S. Molecular detection of enteric viruses and the genetic characterization of porcine astroviruses and sapoviruses in domestic pigs from Slovakian farms. BMC Veterinary Research. 2018. DOI: https://doi.org/10.1186/s12917-018-1640-8

[28] Flores C, Ariyama N, Bennett B, Mena J, Verdugo C, Mor S, et al.. Case Report: First Report and Phylogenetic Analysis of Porcine Astroviruses in Chile. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.764837

[29] Amimo J, Machuka E, Abworo EO, Vlasova A, Pelle R. Whole Genome Sequence Analysis of Porcine Astroviruses Reveals Novel Genetically Diverse Strains Circulating in East African Smallholder Pig Farms. Viruses. 2020. DOI: https://doi.org/10.3390/v12111262

[30] Tao J, Cheng J, Shi Y, Li B, Tang P, Jiao J, et al.. NLRX1 Mediates the Disruption of Intestinal Mucosal Function Caused by Porcine Astrovirus Infection via the Extracellular Regulated Protein Kinases/Myosin Light–Chain Kinase (ERK/MLCK) Pathway. Cells. 2024. DOI: https://doi.org/10.3390/cells13110913

[31] Dong Q, Zhu X, Wang L, Zhang W, Lu L, Li J, et al.. Replication of Porcine Astrovirus Type 1-Infected PK-15 Cells In Vitro Affected by RIG-I and MDA5 Signaling Pathways. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.00701-23

[32] Luo Y, Dong Q, Yi S, Zhang W, Du Y, Fang Q, et al.. Genome-wide CRISPR screening identifies Annexin A1 as a facilitator of porcine astrovirus entry. PLoS Pathogens. 2026. DOI: https://doi.org/10.1371/journal.ppat.1013943

[33] Fang Q, Wang C, Liu H, Wu Q, Liang S, Cen M, et al.. Pathogenic Characteristics of a Porcine Astrovirus Strain Isolated in China. Viruses. 2019. DOI: https://doi.org/10.3390/v11121156

[34] Mi S, Guo S, Xing C, Xiao C, He B, Wu B, et al.. Isolation and Characterization of Porcine Astrovirus 5 from a Classical Swine Fever Virus-Infected Specimen. Journal of Virology. 2020. DOI: https://doi.org/10.1128/JVI.01513-20

[35] He J, Shi K, Shi Y, Yin Y, Feng S, Long F, et al.. Development of a Quadruplex RT-qPCR for the Detection of Porcine Astrovirus, Porcine Sapovirus, Porcine Norovirus, and Porcine Rotavirus A. Pathogens. 2024. DOI: https://doi.org/10.3390/pathogens13121052

[36] Vaishali, Gupta R, Kumar M, Bansal N, Vivek, Kumar P, et al.. Coinfection of porcine astrovirus and other porcine viruses in diarrheic pigs in Haryana, India. Archives of Virology. 2023. DOI: https://doi.org/10.1007/s00705-023-05865-9

[37] Rahe MC, Michael A, Piñeyro P, Groeltz-Thrush J, Derscheid R. Porcine Astrovirus 4 Detection in Lesions of Epitheliotropic Viral Infection in the Porcine Respiratory Tract. Transboundary and Emerging Diseases. 2023. DOI: https://doi.org/10.1155/2023/9113355

[38] Kaur R, Kumar P, Jindal N, Minhas SK, Panghal R, Sheoran D, et al.. Porcine Astrovirus Detection and Characterization in Healthy and Diarrheic Pigs from Haryana, India. Indian Journal of Animal Research. 2023. DOI: https://doi.org/10.18805/ijar.b-5138

[39] Ferreyra FSM, Harmon K, Bradner L, Burrough ER, Derscheid R, Magstadt DR, et al.. Comparative Analysis of Novel Strains of Porcine Astrovirus Type 3 in the USA. Viruses. 2021. DOI: https://doi.org/10.3390/v13091859

[40] Su M, Qi S, Yang D, Guo D, Yin B, Sun D. Coinfection and Genetic Characterization of Porcine Astrovirus in Diarrheic Piglets in China From 2015 to 2018. Frontiers in Veterinary Science. 2020. DOI: https://doi.org/10.3389/fvets.2020.00462

[41] Rawal G, Ferreyra F, Macedo NR, Bradner L, Harmon K, Allison G, et al.. Ecology of Porcine Astrovirus Type 3 in a Herd with Associated Neurologic Disease. Viruses. 2020. DOI: https://doi.org/10.3390/v12090992

[42] Ren K, Wang R, Liu X, Liu Y, Zhang J, Bi J, et al.. Epidemiological investigation and genetic characterization of porcine astrovirus genotypes 2 and 5 in Yunnan province, China. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05311-8

[43] Qin Y, Fang Q, Li X, Li F, Liu H, Wei Z, et al.. Molecular epidemiology and viremia of porcine astrovirus in pigs from Guangxi province of China. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-2217-x

[44] Cai Y, Yin W, Zhou Y, Li B, Ai L, Pan M, et al.. Molecular detection of Porcine astrovirus in Sichuan Province, China. Virology Journal. 2016. DOI: https://doi.org/10.1186/s12985-015-0462-6

[45] Li B, Tao J, Li X, Cheng J, Shi Y, Tang P, et al.. Relevancy Prediction of the Emerging Pathogens with Porcine Diarrhea by Logistic Regression Model. Microorganisms. 2025. DOI: https://doi.org/10.3390/microorganisms13030528

[46] Stamelou E, Giantsis IA, Papageorgiou K, Petridou E, Davidson I, Polizopοulou ZS, et al.. Epidemiology of Astrovirus, Norovirus and Sapovirus in Greek pig farms indicates high prevalence of Mamastrovirus suggesting the potential need for systematic surveillance. Porcine Health Management. 2022. DOI: https://doi.org/10.1186/s40813-021-00245-8

[47] Nie S, Li J, Wang Y, An C, Zhou H, Xu L, et al.. Novel astrovirus and paramyxovirus in Mongolian gerbils (Meriones unguiculatus) from China. Zoological Research. 2022. DOI: https://doi.org/10.24272/j.issn.2095-8137.2021.445

[48] Zhang Q, Liu Q, Opriessnig T, Wen D, Gu K, Jiang Y. Multiplex gel-based PCR assay for the simultaneous detection of 5 genotypes of porcine astroviruses. Journal of Veterinary Diagnostic Investigation. 2022. DOI: https://doi.org/10.1177/10406387221145329

[49] Capai L, Piorkowski G, Maestrini O, Casabianca F, Masse S, Lamballerie XDd, et al.. Detection of porcine enteric viruses (Kobuvirus, Mamastrovirus and Sapelovirus) in domestic pigs in Corsica, France. bioRxiv. 2021. DOI: https://doi.org/10.1371/journal.pone.0260161

[50] László Z, Pankovics P, Reuter G, Cságola A, Bodó K, Gáspár G, et al.. Development and Large-Scale Testing of a Novel One-Step Triplex RT-qPCR Assay for Simultaneous Detection of “Neurotropic” Porcine Sapeloviruses, Teschoviruses (Picornaviridae) and Type 3 Porcine Astroviruses (Astroviridae) in Various Samples including Nasal Swabs. Viruses. 2022. DOI: https://doi.org/10.3390/v14030513

[51] Opriessnig T, Xiao C, Halbur P. Porcine Astrovirus Type 5-Associated Enteritis in Pigs.. Journal of Comparative Pathology. 2020. DOI: https://doi.org/10.1016/j.jcpa.2020.09.014

[52] Goecke NB, Hjulsager C, Kongsted H, Boye M, Boye M, Rasmussen S, et al.. No evidence of enteric viral involvement in the new neonatal porcine diarrhoea syndrome in Danish pigs. BMC Veterinary Research. 2017. DOI: https://doi.org/10.1186/s12917-017-1239-5

[53] Pathania A, Mishra A, Mahajan V, Malik Y. Nested polymerase chain reaction assay for detection of Porcine Astrovirus in pig population. Indian Journal of Animal Sciences. 2026. DOI: https://doi.org/10.56093/ijans.v95i11.166592

[54] Du Y, Liu T, Qin Y, Dong Q, Chen Y, Ouyang K, et al.. Insertion of Exogenous Genes within the ORF1a Coding Region of Porcine Astrovirus. Viruses. 2021. DOI: https://doi.org/10.3390/v13112119

[55] Pathania A, M M, Mahajan V, Malik Y. Duplex reverse transcriptase PCR for concurrent detection of porcine astrovirus and porcine kobuvirus. Indian Journal of Animal Sciences. 2026. DOI: https://doi.org/10.56093/ijans.v95i10.155656